Health Sciences
Bacteria navigate on surfaces using a "sense of touch"
Research
EPFL
EPFL researchers have characterized a mechanism that allows bacteria to direct their movement in response to the mechanical properties of the surfaces the microbes move on — a finding that could help fight certain pathogens.
Illuminating tissue formation
Research
ETH Zurich
Researchers at ETH Zurich have developed a molecule that fluoresces where new tissue is forming in the body. Alongside helping to detect tumours, the molecule could play a significant role in research of wound healing disorders.
Towards a more affordable analysis of air pollution
TechTransfer
EPFL
EPFL scientists have developed a new method for chemical analysis of fine particles that they plan to extend on a large scale – including in developing countries – through an Innosuisse innovation grant award and a new startup.
Toxicity testing on the placenta and embryo
Research
ETH Zurich
Researchers at ETH Zurich have developed a cell culture test to detect substances that are directly or indirectly harmful to embryos. Based on an existing test used for developing new drugs and chemicals, the augmented version is designed to help reduce the number of animal experiments.
In the health lab of the future
Research
ETH Zurich
Rea Lehner has been running the “Future Health Technologies” research programme at the Singapore-ETH Centre since 2020. Together with her team, the ETH researcher is working on the principles of how healthcare can be changed through digital technologies.
Harnessing AI to discover new drugs inspired by nature
Research
ETH Zurich
Artificial intelligence (AI) is able to recognise the biological activity of natural products in a targeted manner, as researchers at ETH Zurich have demonstrated. Moreover, AI helps to find molecules that have the same effect as a natural substance but are easier to manufacture. This opens up huge possibilities for drug discovery, which also have potential to rewrite the rulebook for pharmaceutical research.
Page 5 of 14